Published online Jun 28, 2021. doi: 10.13105/wjma.v9.i3.257
Peer-review started: February 23, 2021
First decision: April 6, 2021
Revised: April 24, 2021
Accepted: June 15, 2021
Article in press: June 15, 2021
Published online: June 28, 2021
Processing time: 139 Days and 7.4 Hours
Gastric adenocarcinoma is a global health concern, and Helicobacter pylori (H. pylori) infection is the main risk factor for its occurrence. Of note, the immune response against the pathogen seems to be a determining factor for gastric oncogenesis, and increasing evidence have emphasized several host and bacterium factors that probably influence in this setting. The development of an inflammatory process against H. pylori involves a wide range of mechanisms such as the activation of pattern recognition receptors and intracellular pathways resulting in the production of proinflammatory cytokines by gastric epithelial cells. This process culminates in the establishment of distinct immune response profiles that result from the cytokine-induced differentiation of T naïve cells into specific T helper cells. Cytokines released from each type of T helper cell orchestrate the immune system and interfere in the development of gastric cancer in idiosyncratic ways. Moreover, variants in genes such as single nucleotide polymorphisms have been associated with variable predispositions for the occurrence of gastric malignancy because they influence both the intensity of gene expression and the affinity of the resultant molecule with its receptor. In addition, various repercussions related to some H. pylori virulence factors seem to substantially influence the host immune response against the infection, and many of them have been associated with gastric tumorigenesis.
Core Tip: Gastric cancer affects more than 1 million people yearly, and Helicobacter pylori (H. pylori) infection is the main risk factor for that malignancy. Moreover, the immune response against the infection seems to play a pivotal role in gastric carcinogenesis. This article provides a broad and updated overview on the main aspects regarding H. pylori infection, immune response, and gastric cancer development.